# A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

> **NCT02418793** · PHASE1 · COMPLETED · sponsor: **OPKO Health, Inc.** · enrollment: 27 (actual)

## Conditions studied

- Hemophilia A
- Hemophilia B

## Interventions

- **DRUG:** MOD-5014

## Key facts

- **NCT ID:** NCT02418793
- **Lead sponsor:** OPKO Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02418793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02418793, "A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02418793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*